Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

German and U.S. team presents omega-3 PUFA analogues

Aug. 11, 2015

Promising antiatherosclerosis activity of human FOXP3 gene therapy in mice

Aug. 7, 2015

ISIS Pharmaceuticals presents preliminary data for ISIS-TTRRx

Aug. 6, 2015

Gene delivery therapy shows promising effects on experimental autoimmune myocarditis

Aug. 5, 2015

Abbott makes deals with heart valve device developers Tendyne and Cephea

Aug. 4, 2015

Merck & Co. discloses ROMK channel blockers

Aug. 4, 2015

Bayer starts pilot study of BAY-1142524 in left ventricular dysfunction after MI

Aug. 4, 2015

Novel apelin receptor agonist shows promise as vasodilator

Aug. 3, 2015

University of Sydney to study Cymerus stem cells in heart disease models

Aug. 3, 2015

Bone marrow-derived mesenchymal stromal cell therapy beneficial in severe ischemic heart failure

July 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...